Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids

Journal of Neuroscience

Volumn 30, Issue 46, 2010, Pages 15400-15408

  Muscoli, Carolina ^a,b,c   Doyle, Tim ^a   Dagostino, Concetta ^c   Bryant, Leesa ^a   Chen, Zhoumou ^a   Watkins, Linda R ^d   Ryerse, Jan ^a   Bieberich, Erhard ^e   Neumman, William ^f   Salvemini, Daniela ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c Instituto di Ricovero e Cura a Carattere Scientifico   (Italy)

^d UNIVERSITY OF COLORADO   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MORPHINE SULFATE; SPHINGOSINE 1 PHOSPHATE; THERMOZYMOCIDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ASTROCYTE; HYPERALGESIA; MALE; MICROGLIA; NERVE CELL EXCITABILITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; HYPERALGESIA; LYSOPHOSPHOLIPIDS; MALE; NEUROGLIA; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOLIPIDS; SPHINGOSINE;

EID: 78449264889     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2391-10.2010     Document Type: Article

References (70)

1. Arnér S, Rawal N, Gustafsson LL (1988) Clinical experience of long-term treatment with epidural and intrathecal opioids: a nationwide survey. Acta Anaesthesiol Scand 32:253-259. (Pubitemid 18098972)
2. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624. (Pubitemid 20080360)
3. Bryant L, Doyle T, Chen Z, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Mazzon E, Petrusca DN, Petrache I, Salvemini D (2009) Spinal ceramide and neuronal apoptosis in morphine antinociceptive tolerance. Neurosci Lett 463:49-53.
4. Chiang CY, Wang J, Xie YF, Zhang S, Hu JW, Dostrovsky JO, Sessle BJ (2007) Astroglial glutamate-glutamine shuttle is involved in central sensitization of nociceptive neurons in rat medullary dorsal horn. J Neurosci 27: 9068-9076. (Pubitemid 47312060)
5. Claus RA, Bunck AC, Bockmeyer CL, Brunkhorst FM, Lösche W, Kinscherf R, Deigner HP (2005) Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis. FASEB J 19: 1719-1721. (Pubitemid 41429541)
6. Cui Y, Chen Y, Zhi JL, Guo RX, Feng JQ, Chen PX (2006) Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res 1069:235-243. (Pubitemid 43145918)
7. Cuzzocrea S, Genovese T, Mazzon E, Esposito E, Crisafulli C, Di Paola R, Bramanti P, Salvemini D (2009) Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice. Shock 31:170-177.
8. D'Amour F (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74-79.
9. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1-105.
10. Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 1758: 1957-1977.
11. Delogu G, Famularo G, Amati F, Signore L, Antonucci A, Trinchieri V, Di Marzio L, Cifone MG (1999) Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. Crit Care Med 27:2413-2417.
12. Doyle T, Bryant L, Muscoli C, Cuzzocrea S, Esposito E, Chen Z, Salvemini D (2010) Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci Lett 483:85-89.
13. Foley KM (1995) Misconceptions and controversies regarding the use of opioids in cancer pain. Anticancer Drugs 6 [Suppl 3]:4-13.
14. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962-5969. (Pubitemid 37187498)
15. Görg B, Wettstein M, Metzger S, Schliess F, Häussinger D (2005) Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology 41:1065-1073.
16. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9:139-150.
17. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
18. Jolly PS, Rosenfeldt HM, Milstien S, Spiegel S (2002) The roles of sphingosine-1-phosphate in asthma. Mol Immunol 38:1239-1245.
19. Keller M, Lidington D, Vogel L, Peter BF, Sohn HY, Pagano PJ, Pitson S, Spiegel S, Pohl U, Bolz SS (2006) Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J 20:702-704. (Pubitemid 46671187)
20. King T, Vardanyan A, Majuta L, Melemedjian O, Nagle R, Cress AE, Vanderah TW, Lai J, Porreca F (2007) Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain 132:154-168.
21. Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, Iwasaki T, Sano H, Saba JD, Tam YY (2006) Sphingosine 1-phosphate/ sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthritis Rheum 54:742-753.
22. Krishnamurthy K, Dasgupta S, Bieberich E (2007) Development and characterization of a novel anti-ceramide antibody. J Lipid Res 48:968-975.
23. Lai WQ, Irwan AW, Goh HH, Howe HS, Yu DT, Valle-Oñate R, McInnes IB, Melendez AJ, Leung BP (2008) Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis. J Immunol 181: 8010-8017.
24. Latremoliere A, Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10:895-926.
25. Lee C, Xu DZ, Feketeova E, Kannan KB, Yun JK, Deitch EA, Fekete Z, Livingston DH, Hauser CJ (2004) Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. J Trauma 57:955-960.
26. Maines LW, Fitzpatrick LR, French KJ, Zhuang Y, Xia Z, Keller SN, Upson JJ, Smith CD (2008) Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase. Dig Dis Sci 53:997-1012.
27. Mao J, Price DD, Mayer DJ (1995) Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 62: 259-274.
28. Melendez AJ (2008) Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets. Biochim Biophys Acta 1784:66-75.
29. Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23-36.
30. Miñana MD, Kosenko E, Marcaida G, Hermenegildo C, Montoliu C, Grisolía S, Felipo V (1997) Modulation of glutamine synthesis in cultured astrocytes by nitric oxide. Cell Mol Neurobiol 17:433-445. (Pubitemid 27329151)
31. Muscoli C, Visalli V, Colica C, Nisticò R, Palma E, Costa N, Rotiroti D, Nisticò G, Mollace V (2005) The effect of inflammatory stimuli on NMDA-related activation of glutamine synthase in human cultured astroglial cells. Neurosci Lett 373:184-188. (Pubitemid 41556555)
32. Muscoli C, Cuzzocrea S, Ndengele MM, Mollace V, Porreca F, Fabrizi F, Esposito E, Masini E, Matuschak GM, Salvemini D (2007) Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J Clin Invest 117:3530-3539.
33. Nakagawa T, Ozawa T, Shige K, Yamamoto R, Minami M, Satoh M (2001) Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur J Pharmacol 419:39-45.
34. Narita M, Yoshida T, Nakajima M, Narita M, Miyatake M, Takagi T, Yajima Y, Suzuki T (2006) Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J Neurochem 97: 1337-1348. (Pubitemid 43725573)
35. Nayak D, Huo Y, Kwang WX, Pushparaj PN, Kumar SD, Ling EA, Dheen ST (2010) Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 166:132-144.
36. Ndengele MM, Cuzzocrea S, Esposito E, Mazzon E, Di Paola R, Matuschak GM, Salvemini D (2008) Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. FASEB J 22:3154-3164.
37. Ndengele MM, Cuzzocrea S, Masini E, Vinci MC, Esposito E, Muscoli C, Petrusca DN, Mollace V, Mazzon E, Li D, Petrache I, Matuschak GM, Salvemini D (2009) Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation. J Pharmacol Exp Ther 329:64-75.
38. Nishiuma T, Nishimura Y, Okada T, Kuramoto E, Kotani Y, Jahangeer S, Nakamura S (2008) Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol 294:L1085-L1093.
39. Ossipov MH, Lai J, Vanderah TW, Porreca F (2003) Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 73:783-800. (Pubitemid 36703272)
40. Pushparaj PN, H'Ng SC, Melendez AJ (2008) Refining siRNA in vivo transfection: silencing SPHK1 reveals its key role in C5a-induced inflammation in vivo. Int J Biochem Cell Biol 40:1817-1825.
41. Ramos KM, Lewis MT, Morgan KN, Crysdale NY, Kroll JL, Taylor FR, Harrison JA, Sloane EM, Maier SF, Watkins LR (2010) Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 169:1888-1900.
42. Renfrey S, Downton C, Featherstone J (2003) The painful reality. Nat Rev Drug Discov 2:175-176.
43. Romero-Sandoval A, Chai N, Nutile-McMenemy N, Deleo JA (2008a) A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res 1219:116-126.
44. Romero-Sandoval EA, Horvath RJ, DeLeo JA (2008b) Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 9:726-734.
45. Salvemini D, Neumann W (2010) Targeting peroxynitrite driven nitroxidative stress with synzymes: a novel therapeutic approach in chronic pain management. Life Sci 86:604-614.
46. Salvemini D, Neumann WL (2009) Peroxynitrite: a strategic linchpin of opioid analgesic tolerance. Trends Pharmacol Sci 30:194-202.
47. Salvemini D, Jensen MP, Riley DP, Misko TP (1998) Therapeutic manipulations of peroxynitrite. Drug News Perspect 11:204-214.
48. Schoeniger-Skinner DK, Ledeboer A, Frank MG, Milligan ED, Poole S, Martin D, Maier SF, Watkins LR (2007) Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun 21:660-667. (Pubitemid 46844802)
49. Simonnet G, Rivat C (2003) Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport 14:1-7.
50. Snider AJ, Kawamori T, Bradshaw SG, Orr KA, Gilkeson GS, Hannun YA, Obeid LM (2009) A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J 23:143-152.
51. Størkson RV, Kjørsvik A, Tjølsen A, Hole K (1996) Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65:167-172. (Pubitemid 26132817)
52. Suárez I, Bodega G, Fernández B (2002) Glutamine synthetase in brain: effect of ammonia. Neurochem Int 41:123-142.
53. Taha TA, Argraves KM, Obeid LM (2004) Sphingosine-1-phosphate recep- tors: receptor specificity versus functional redundancy. Biochim Biophys Acta 1682:48-55.
54. Takabe K, Paugh SW, Milstien S, Spiegel S (2008) "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60:181-195.
55. Takagi N, Logan R, Teves L, Wallace MC, Gurd JW (2000) Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia. J Neurochem 74:169-178.
56. Tanga FY, Nutile-McMenemy N, DeLeo JA (2005) The CNS role of Tolllike receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 102:5856-5861.
57. Tanga FY, Raghavendra V, Nutile-McMenemy N, Marks A, Deleo JA (2006) Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain. Neuroscience 140:1003-1010. (Pubitemid 43767469)
58. Taylor DA, Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11-18.
59. Trotti D, Rossi D, Gjesdal O, Levy LM, Racagni G, Danbolt NC, Volterra A (1996) Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 271:5976-5979.
60. Trotti D, Rolfs A, Danbolt NC, Brown RH Jr, Hediger MA (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 2:848.
61. Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
62. Vera-Portocarrero LP, Zhang ET, King T, Ossipov MH, Vanderah TW, Lai J, Porreca F (2007) Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain 129:35-45.
63. Wang Z, Ma W, Chabot JG, Quirion R (2009) Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J 23:2576-2586.
64. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, Muscoli C, Mollace V, Ndengele M, Ischiropoulos H, Salvemini D (2004) A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 309:869-878. (Pubitemid 38669673)
65. Waniewski RA, Martin DL (1986) Exogenous glutamate is metabolized to glutamine and exported by rat primary astrocyte cultures. J Neurochem 47:304-313.
66. Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455.
67. Watkins LR, Hutchinson MR, Johnston IN, Maier SF (2005) Glia: novel counter-regulators of opioid analgesia. Trends Neurosci 28:661-669.
68. Watkins LR, Hutchinson MR, Rice KC, Maier SF (2009) The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 30:581-591.
69. + current in rat sensory neurons. J Physiol 544: 385-402.
70. Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD (2006) Sphingosine- 1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. J Neurophysiol 96: 1042-1052. (Pubitemid 44371500)